Literature DB >> 15702261

Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements.

Pisit Pitukcheewanont1, David Safani, Joseph Church, Vicente Gilsanz.   

Abstract

Investigators have found that dual-energy X-ray absorptiometry (DXA) of areal bone mineral density (BMD) values in HIV-1 infected children and adolescents are reduced. Volumetric bone density (BD) measured by quantitative computed tomography (CT) in this population has not been studied. This study was designed to evaluate bone measurements in HIV-1 infected children and adolescents using DXA and CT. Fifty-eight children and adolescents (32 females and 26 males with a mean age +/- SD of 12.0+/-3.9 years, age range 5.0-19.4 years) with perinatally acquired HIV-1 infection underwent simultaneous bone area and density evaluation by DXA and CT. Height and weight measurements as well as pubertal assessment were performed on the same day. All but four subjects were receiving highly active antiretroviral therapy (HAART). Subjects were matched with healthy children and adolescents for age, gender, and ethnicity. HIV-1 infected children were significantly shorter (P <0.001), lighter (P <0.005), and had delayed puberty (P <0.001) compared to controls. Using DXA, HIV-1 infected subjects had significantly less bone area (P <0.001), bone mineral content (BMC) (P <0.005), and BMD (P <0.05) at the vertebral level compared to controls. In addition, bone area (P <0.001), BMC (P <0.001), and BMD (P <0.005) of the whole body were also reduced relative to controls. In contrast, using CT, HIV-1 infected subjects had similar vertebral BD compared to controls, but smaller vertebral height and cross-sectional area (CSA) (P =0.01 and P <0.005, respectively). DXA Z-scores provided values significantly lower than CT Z-scores in the HIV-1 infected population (P <0.01). After accounting for weight and vertebral height, stepwise multiple regression demonstrated that the prediction of CT BD values of L1 to L3 from DXA values of these vertebrae was significantly improved. HIV-1 infected children and adolescents have lower vertebral and whole body BMC and BMD DXA measures. In contrast, vertebral BD measurements by CT are normal. The lower bone measurements were primarily due to the decreased bone and body size of the HIV-1 subjects.

Entities:  

Mesh:

Year:  2005        PMID: 15702261     DOI: 10.1007/s00198-005-1849-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  17 in total

1.  Bone mineral content is lower in prepubertal HIV-infected children.

Authors:  Stephen M Arpadi; Mary Horlick; John Thornton; Patricia A Cuff; Jack Wang; Donald P Kotler
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

2.  Bone mineral content in girls perinatally infected with HIV.

Authors:  K O O'Brien; M Razavi; R A Henderson; B Caballero; K J Ellis
Journal:  Am J Clin Nutr       Date:  2001-04       Impact factor: 7.045

Review 3.  HIV disease and the endocrine system.

Authors:  S K Grinspoon; J P Bilezikian
Journal:  N Engl J Med       Date:  1992-11-05       Impact factor: 91.245

4.  Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography.

Authors:  W A Kalender
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

5.  New approaches for interpreting projected bone densitometry data.

Authors:  D R Carter; M L Bouxsein; R Marcus
Journal:  J Bone Miner Res       Date:  1992-02       Impact factor: 6.741

6.  Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants.

Authors:  A Prentice; T J Parsons; T J Cole
Journal:  Am J Clin Nutr       Date:  1994-12       Impact factor: 7.045

7.  Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia.

Authors:  M B Leonard; K J Propert; B S Zemel; V A Stallings; H I Feldman
Journal:  J Pediatr       Date:  1999-08       Impact factor: 4.406

Review 8.  Bone density in children: a review of the available techniques and indications.

Authors:  V Gilsanz
Journal:  Eur J Radiol       Date:  1998-01       Impact factor: 3.528

Review 9.  Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls.

Authors:  L K Bachrach
Journal:  J Pediatr Endocrinol Metab       Date:  2000-09       Impact factor: 1.634

Review 10.  Diagnosis of osteoporosis in men, premenopausal women, and children.

Authors: 
Journal:  J Clin Densitom       Date:  2004       Impact factor: 2.963

View more
  13 in total

Review 1.  Bone and vitamin D metabolism in HIV.

Authors:  Aristotle Panayiotopoulos; Nandini Bhat; Amrit Bhangoo
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 2.  HIV and Bone Complications: Understudied Populations and New Management Strategies.

Authors:  Michael T Yin; Todd T Brown
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

3.  Normalization of cortical bone density in children and adolescents with hyperthyroidism treated with antithyroid medication.

Authors:  N Numbenjapon; G Costin; P Pitukcheewanont
Journal:  Osteoporos Int       Date:  2011-12-21       Impact factor: 4.507

Review 4.  Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

Authors:  Grace A McComsey; Pablo Tebas; Elizabeth Shane; Michael T Yin; E Turner Overton; Jeannie S Huang; Grace M Aldrovandi; Sandra W Cardoso; Jorge L Santana; Todd T Brown
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

5.  Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life.

Authors:  Michael T Yin; Emily Lund; Jayesh Shah; Chiyuan A Zhang; Marc Foca; Natalie Neu; Kyle K Nishiyama; Bin Zhou; Xiangdong E Guo; John Nelson; David L Bell; Elizabeth Shane; Stephen M Arpadi
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

6.  Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy.

Authors:  P Pitukcheewanont; N Numbenjapon; D Safani; S Rossmiller; V Gilsanz; G Costin
Journal:  Osteoporos Int       Date:  2010-09-09       Impact factor: 4.507

7.  Trabecular and cortical microarchitecture in postmenopausal HIV-infected women.

Authors:  Michael T Yin; Aimee Shu; Chiyuan A Zhang; Stephanie Boutroy; Donald J McMahon; David C Ferris; Ivelisse Colon; Elizabeth Shane
Journal:  Calcif Tissue Int       Date:  2013-03-05       Impact factor: 4.333

8.  Bone health in HIV-infected children, adolescents and young adults: a systematic review.

Authors:  Stephen M Arpadi; Stephanie Shiau; Charlotte Marx-Arpadi; Michael T Yin
Journal:  J AIDS Clin Res       Date:  2014-11-09

9.  Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.

Authors:  Denise L Jacobson; Jane C Lindsey; Catherine M Gordon; Jack Moye; Dana S Hardin; Kathleen Mulligan; Grace M Aldrovandi
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

Review 10.  Metabolic complications and treatment of perinatally HIV-infected children and adolescents.

Authors:  Linda Barlow-Mosha; Allison Ross Eckard; Grace A McComsey; Philippa M Musoke
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.